Dr Leanne Mooney
- Honorary Clinical Research Fellow (School of Cardiovascular & Metabolic Health)
Publications
2026
Elbassioni, A. A. M. et al. (2026) Targeting Runx1 protects against heart failure with preserved ejection fraction. Cardiovascular Research, (Accepted for Publication)
2023
Mooney, Leanne, Jackson, Colette E., Adamson, Carly, McConnachie, Alex ORCID: https://orcid.org/0000-0002-7262-7000, Welsh, Paul
ORCID: https://orcid.org/0000-0002-7970-3643, Myles, Rachel C.
ORCID: https://orcid.org/0000-0003-4670-361X, McMurray, John J.V.
ORCID: https://orcid.org/0000-0002-6317-3975, Jhund, Pardeep S.
ORCID: https://orcid.org/0000-0003-4306-5317, Petrie, Mark C.
ORCID: https://orcid.org/0000-0002-6333-9496 and Lang, Ninian N.
ORCID: https://orcid.org/0000-0001-8441-6887
(2023)
Adverse outcomes associated with interleukin-6 in patients recently hospitalized for heart failure with preserved ejection fraction.
Circulation: Heart Failure, 16(4),
e010051.
(doi: 10.1161/CIRCHEARTFAILURE.122.010051)
(PMID:36896709)
(PMCID:PMC10101136)
2022
Welsh, P. et al. (2022) Reference ranges for NT-proBNP (N-terminal pro-B-type natriuretic peptide) and risk factors for higher NT-proBNP concentrations in a large general population cohort. Circulation: Heart Failure, 15(10), pp. 957-967. (doi: 10.1161/CIRCHEARTFAILURE.121.009427) (PMID:36098049) (PMCID:PMC9561238)
2021
Mooney, L. et al. (2021) Impact of chronic obstructive pulmonary disease in patients with heart failure with preserved ejection fraction: insights from PARAGON‐HF. Journal of the American Heart Association, 10(23), e021494. (doi: 10.1161/JAHA.121.021494) (PMID:34796742) (PMCID:PMC9075384)
Mooney, Leanne, Goodyear, Carl S. ORCID: https://orcid.org/0000-0001-5926-5941, Chandra, Tamir, Kirschner, Kristina
ORCID: https://orcid.org/0000-0001-7607-8670, Copland, Mhairi
ORCID: https://orcid.org/0000-0002-7655-016X, Petrie, Mark C.
ORCID: https://orcid.org/0000-0002-6333-9496 and Lang, Ninian N.
ORCID: https://orcid.org/0000-0001-8441-6887
(2021)
Clonal haematopoiesis of indeterminate potential: intersections between inflammation, vascular disease and heart failure.
Clinical Science, 135(7),
pp. 991-1007.
(doi: 10.1042/CS20200306)
(PMID:33861346)
(PMCID:PMC8055963)
Ehteshami-Afshar, S. et al. (2021) Clinical characteristics and outcomes of patients with heart failure with reduced ejection fraction and chronic obstructive pulmonary disease: insights from PARADIGM-HF. Journal of the American Heart Association, 10(4), e019238. (doi: 10.1161/JAHA.120.019238) (PMID:33522249) (PMCID:PMC7955331)
2019
Ferry, A. V. et al. (2019) Presenting symptoms in men and women diagnosed with myocardial infarction using sex‐specific criteria. Journal of the American Heart Association, 8(17), e012307. (doi: 10.1161/JAHA.119.012307) (PMID:31431112) (PMCID:PMC6755854)
Articles
Elbassioni, A. A. M. et al. (2026) Targeting Runx1 protects against heart failure with preserved ejection fraction. Cardiovascular Research, (Accepted for Publication)
Mooney, Leanne, Jackson, Colette E., Adamson, Carly, McConnachie, Alex ORCID: https://orcid.org/0000-0002-7262-7000, Welsh, Paul
ORCID: https://orcid.org/0000-0002-7970-3643, Myles, Rachel C.
ORCID: https://orcid.org/0000-0003-4670-361X, McMurray, John J.V.
ORCID: https://orcid.org/0000-0002-6317-3975, Jhund, Pardeep S.
ORCID: https://orcid.org/0000-0003-4306-5317, Petrie, Mark C.
ORCID: https://orcid.org/0000-0002-6333-9496 and Lang, Ninian N.
ORCID: https://orcid.org/0000-0001-8441-6887
(2023)
Adverse outcomes associated with interleukin-6 in patients recently hospitalized for heart failure with preserved ejection fraction.
Circulation: Heart Failure, 16(4),
e010051.
(doi: 10.1161/CIRCHEARTFAILURE.122.010051)
(PMID:36896709)
(PMCID:PMC10101136)
Welsh, P. et al. (2022) Reference ranges for NT-proBNP (N-terminal pro-B-type natriuretic peptide) and risk factors for higher NT-proBNP concentrations in a large general population cohort. Circulation: Heart Failure, 15(10), pp. 957-967. (doi: 10.1161/CIRCHEARTFAILURE.121.009427) (PMID:36098049) (PMCID:PMC9561238)
Mooney, L. et al. (2021) Impact of chronic obstructive pulmonary disease in patients with heart failure with preserved ejection fraction: insights from PARAGON‐HF. Journal of the American Heart Association, 10(23), e021494. (doi: 10.1161/JAHA.121.021494) (PMID:34796742) (PMCID:PMC9075384)
Mooney, Leanne, Goodyear, Carl S. ORCID: https://orcid.org/0000-0001-5926-5941, Chandra, Tamir, Kirschner, Kristina
ORCID: https://orcid.org/0000-0001-7607-8670, Copland, Mhairi
ORCID: https://orcid.org/0000-0002-7655-016X, Petrie, Mark C.
ORCID: https://orcid.org/0000-0002-6333-9496 and Lang, Ninian N.
ORCID: https://orcid.org/0000-0001-8441-6887
(2021)
Clonal haematopoiesis of indeterminate potential: intersections between inflammation, vascular disease and heart failure.
Clinical Science, 135(7),
pp. 991-1007.
(doi: 10.1042/CS20200306)
(PMID:33861346)
(PMCID:PMC8055963)
Ehteshami-Afshar, S. et al. (2021) Clinical characteristics and outcomes of patients with heart failure with reduced ejection fraction and chronic obstructive pulmonary disease: insights from PARADIGM-HF. Journal of the American Heart Association, 10(4), e019238. (doi: 10.1161/JAHA.120.019238) (PMID:33522249) (PMCID:PMC7955331)
Ferry, A. V. et al. (2019) Presenting symptoms in men and women diagnosed with myocardial infarction using sex‐specific criteria. Journal of the American Heart Association, 8(17), e012307. (doi: 10.1161/JAHA.119.012307) (PMID:31431112) (PMCID:PMC6755854)